Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
iLex Medical Ltd. is a medical distribution company primarily operating in Israel, specializing in a range of medical devices and consumables. The company differentiates itself through its strong relationships with healthcare providers and a diversified product portfolio that includes surgical instruments and diagnostic equipment, catering to both public and private healthcare sectors.
iLex Medical generates revenue by distributing medical devices and consumables to hospitals and clinics, leveraging its established partnerships to secure long-term contracts. The company benefits from pricing power due to its specialized offerings and customer loyalty in a fragmented market.
Changes in healthcare spending in Israel, particularly public health budgets
Regulatory changes affecting medical device approvals
Market share gains from competitors in the medical distribution space
New product launches that expand the existing portfolio
Technological disruption in medical devices leading to obsolescence
Regulatory changes that could increase compliance costs
Increased competition from larger global distributors
Potential price wars with local competitors
Low liquidity due to minimal free cash flow generation
Dependence on a few key suppliers for critical products
moderate - The company's performance is somewhat linked to GDP growth and healthcare spending, which can fluctuate with economic conditions.
Minimal impact as the company has low debt levels, but rising rates could affect overall healthcare spending indirectly.
minimal - The company operates with a low debt-to-equity ratio, indicating limited reliance on external financing.
value - The stock is trading at a low price-to-sales ratio, appealing to value investors looking for undervalued opportunities.
moderate - The stock has shown significant price fluctuations, particularly in response to earnings reports and market conditions.